ES2051862T3 - Un metodo para producir un medicamento que tiene un efecto catartico. - Google Patents

Un metodo para producir un medicamento que tiene un efecto catartico.

Info

Publication number
ES2051862T3
ES2051862T3 ES88308842T ES88308842T ES2051862T3 ES 2051862 T3 ES2051862 T3 ES 2051862T3 ES 88308842 T ES88308842 T ES 88308842T ES 88308842 T ES88308842 T ES 88308842T ES 2051862 T3 ES2051862 T3 ES 2051862T3
Authority
ES
Spain
Prior art keywords
effect
catartical
drug
produce
catharic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88308842T
Other languages
English (en)
Inventor
Ryuzo Ueno
Ryuji Ueno
Sachiko Kuno
Tomio Oda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ueno Seiyaku Oyo Kenkyujo KK
Original Assignee
Ueno Seiyaku Oyo Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo KK filed Critical Ueno Seiyaku Oyo Kenkyujo KK
Application granted granted Critical
Publication of ES2051862T3 publication Critical patent/ES2051862T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Ceramic Products (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)

Abstract

LA INVENCION PRESENTE TRATA SOBRE CATARTICOS QUE COMPRENDEN 15 - CETO - 16 - HALOGEN - PGS COMO INGREDIENTE ESENCIAL SIN SOMETERSE A EFECTOS COLATERALES; EL EFECTO CATARTICO ESTA CAUSADO PRINCIPALMENTE A TRAVES DE UN EFECTO DE ENTEROCONCENTRACION.
ES88308842T 1987-10-02 1988-09-23 Un metodo para producir un medicamento que tiene un efecto catartico. Expired - Lifetime ES2051862T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25016387 1987-10-02

Publications (1)

Publication Number Publication Date
ES2051862T3 true ES2051862T3 (es) 1994-07-01

Family

ID=17203760

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88308842T Expired - Lifetime ES2051862T3 (es) 1987-10-02 1988-09-23 Un metodo para producir un medicamento que tiene un efecto catartico.

Country Status (12)

Country Link
EP (1) EP0310305B1 (es)
KR (1) KR930001833B1 (es)
AT (1) ATE78465T1 (es)
AU (1) AU609883B2 (es)
CA (1) CA1312014C (es)
DE (1) DE3873007T2 (es)
ES (1) ES2051862T3 (es)
GB (1) GB2210556B (es)
GR (1) GR3005681T3 (es)
NZ (1) NZ226362A (es)
OA (1) OA09016A (es)
ZA (1) ZA887260B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
DE69006964T2 (de) * 1989-07-27 1994-06-09 Ueno Seiyaku Oyo Kenkyujo Kk Behandlung von Hyperlipidemia mit 15-keto-Prostaglandin-Verbindungen.
ATE122563T1 (de) * 1989-07-27 1995-06-15 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von 15-keto-prostansäure-derivaten zur herstellung eines medikaments für die verbesserung der ausscheidung des kaliumions.
EP0415564B1 (en) * 1989-08-09 1995-04-26 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Use of prostanoic acid derivaties for the manufacture of a medicament for improvement of excretion of nonprotein nitrogen into the intestine
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
CA2030344C (en) 1989-11-22 2000-04-18 Ryuji Ueno Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
TW249226B (es) * 1990-04-04 1995-06-11 Aderk Ueno Kk
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
EP0503887B1 (en) * 1991-03-14 1996-08-28 R-Tech Ueno Ltd. Promotion of wound-healing with 15-keto-prostaglandin compounds
CA2150287C (en) * 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
AR026046A1 (es) 1999-10-15 2002-12-26 R Tech Ueno Ltd NUEVA COMPOSICIoN Y MÉTODO PARA ESTABILIZAR LA MISMA
US6414016B1 (en) 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
NZ529406A (en) * 2001-05-18 2005-09-30 Sucampo Ag Halogenated prostaglandin derivatives for treating constipation and cleansing the gastrointestinal tract
MXPA04002006A (es) 2001-08-31 2004-06-07 Sucampo Ag Analogos de prostagladina como abridor del canal de cloruro.
TWI331920B (en) 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
TWI263505B (en) * 2001-11-19 2006-10-11 Sucampo Ag Pharmaceutical composition comprising a C1C-2 channel opener

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4410720A (en) * 1973-08-06 1983-10-18 Hoffmann-La Roche Inc. 16-Fluoro prostaglandins
US4163016A (en) * 1977-07-05 1979-07-31 Hoffmann-La Roche Inc. 16-Substituted prostaglandins
JPS5626830A (en) * 1979-08-10 1981-03-16 Kuraray Co Ltd Hydroformylation of lower olefin
US4374856A (en) * 1980-09-10 1983-02-22 The Upjohn Company Liver cytoprotection using PGE's
GB8324004D0 (en) * 1983-09-07 1983-10-12 Erba Farmitalia 16-fluoro-16 17-didehydro prostanoids
GB2202468A (en) * 1987-03-25 1988-09-28 Smidth & Co As F L Cyclone
ES2038289T3 (es) * 1987-05-15 1993-07-16 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Utilizacion de 15-ceto-pges para la fabricacion de un medicamento para aumentar la temperatura corporal.
AU604156B2 (en) * 1988-09-14 1990-12-06 R-Tech Ueno, Ltd. Prostaglandins of the F series

Also Published As

Publication number Publication date
DE3873007D1 (de) 1992-08-27
EP0310305B1 (en) 1992-07-22
GB8822455D0 (en) 1988-10-26
GB2210556A (en) 1989-06-14
EP0310305A2 (en) 1989-04-05
ZA887260B (en) 1989-06-28
GB2210556B (en) 1991-07-17
EP0310305A3 (en) 1989-06-14
ATE78465T1 (de) 1992-08-15
CA1312014C (en) 1992-12-29
AU2292088A (en) 1989-04-06
AU609883B2 (en) 1991-05-09
DE3873007T2 (de) 1992-12-03
GR3005681T3 (es) 1993-06-07
KR890006241A (ko) 1989-06-12
KR930001833B1 (ko) 1993-03-15
NZ226362A (en) 1991-07-26
OA09016A (fr) 1991-03-31

Similar Documents

Publication Publication Date Title
ES2051862T3 (es) Un metodo para producir un medicamento que tiene un efecto catartico.
ES546445A0 (es) Proceso para preparar un derivado del bencimidazol.
ES518667A0 (es) Un procedimiento para la produccion de un derivado de carbostirilo.
ES2022610B3 (es) Compuestos para potenciar la permeabilidad de la piel que utilizan esteres de sacarosa.
ES2056105T3 (es) Di-t-butilfenoles sustituidos.
PT98291A (pt) Processo para a preparacao de composicoes farmaceuticas contendo flupirtina para combater distensoes musculares
ES2045180T3 (es) Nuevo procedimiento para la obtencion de 4-aciloxi-3-hidroxietil-azetidinonas.
MX9307644A (es) Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo.
ES2168766T3 (es) Preparacion farmaceutica que incluye el propeptido vwf.
MX9304793A (es) Glicanas de actividad inmunoestimulante.
MX9304399A (es) Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados.
MA19046A1 (fr) Nouveau derive d'acides i-(cyclohexyl) -4-aryl-4-piperidinecarboxylique .
ES503502A0 (es) Un procedimiento para la produccion de un derivado de pripe-razina.
ES557075A0 (es) Procedimiento para preparar un derivado de 1,3-oxazolidina-2-ona.
MX9302419A (es) Derivados de acido tetronico, tiotetronico y tetramico.
MX166685B (es) Proceso para la preparacion de alcanosulfonamidas y arenosulfonamidas
ES522418A0 (es) Un procedimiento para preparar -15-desoxiespergualina.
ES530212A0 (es) Un procedimiento para la produccion de un derivado de 2-amino-tiazol.
JPS538949A (en) Hydraulic elevator
SE7709852L (sv) Sett att framstella ett nytt pyrimidinderivat
DK452788A (da) Smertestillende praeparat
JPS5221176A (en) Box for driving away harmful birds
ES544241A0 (es) Un procedimiento para producir un derivado de 4h-3,1-benzo- xazina
ES2039290T3 (es) Procedimiento para preparar nuevos esteres aralquilicos.
ES485964A0 (es) Un procedimiento para la preparacion de un derivado de 1-4 bis(acetoacetilamino)-2,5-dimetilbenceno

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 310305

Country of ref document: ES